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Background: There is considerable interest in understanding the immunological variables that
have the greatest influence on the effectiveness of sensitization by contact allergens, particu-
larly in the context of developing new paradigms for risk assessment of novel compounds.
Objectives: To examine the relationship between patch test score for three different contact
allergens and the characteristics of T cell responses.
Methods: A total of 192 patients with confirmed nickel, p-phenylenediamine (PPD) or
methylisothiazolinone (MI) allergy were recruited from the Contact Dermatitis Investigation Unit
at Salford Royal Hospital. Severity of allergy was scored by the use of patch testing, peripheral
blood lymphocytes were characterized for T cell phenotype by flow cytometry, and proliferative
activity was characterized by radiolabelled thymidine incorporation. Comparisons were drawn with
buffy coat samples from healthy volunteers.
Results: Patch test positivity for nickel, PPD and MI was associated with changes in the pheno-
type of peripheral blood T cells: increases in naïve cells, decreases in regulatory T cell frequency
and the CD4+/CD8hi ratio, and increased expression of the skin-homing marker cutaneous lym-
phocyte antigen (CLA), particularly for those patients with a +++ patch test score.
Conclusions: This increased understanding of the characteristics of the T cell responses to con-
tact allergens may provide parameters with which to better measure health risks associated with
skin sensitization.
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1 | INTRODUCTION
Skin sensitization resulting in allergic contact dermatitis is an impor-
tant health issue, and it is now clear that many hundreds of
chemicals, possibly in excess of several thousands, have some poten-
tial to cause skin sensitization.1 There remains considerable interest
in defining the cellular and molecular mechanisms through which skin
sensitization is acquired and allergic contact dermatitis is elicited,
particularly in the context of developing new paradigms for risk
assessment of novel compounds. Of particular relevance are the
nature and dynamics of T lymphocyte responses to contact allergens,
and contributions made by functional subpopulations and differenti-
ated subsets of T cells.2–7
One important tool for the characterization of human T cell
responses to contact allergens is the lymphocyte transformation test,
in which the proliferation of cultured T lymphocytes induced by con-
tact allergens, or by contact allergens conjugated with proteins, is
measured.8–15 Experience with the lymphocyte transformation test
has been predominantly with metals, and in particular nickel, although
somewhat variable results have also been reported with certain
organic contact allergens, including: 2,4-dinitrochlorobenzene,9
methylisothiazolinone (MI),7 and p-phenylenediamine (PPD).11,12
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In the present investigations, the lymphocyte transformation test
was used to explore further the characteristics of T lymphocyte
responses to nickel (as nickel sulfate), and to PPD, which is a proven
contact allergen in hair dyes and henna tattoos1,16 (delivered in cul-
ture as a hapten-protein conjugate). Furthermore, the relative fre-
quencies of discrete subpopulations of T lymphocytes were measured
in subjects sensitized to PPD or nickel. In previous investigations of
subjects with allergic contact dermatitis caused by MI, it was found
that there was an association between skin sensitization and the rela-
tive frequencies of CD4+ and CD8+ naïve, memory and effector T lym-
phocytes.7 Comparable studies were conducted here with PPD and
nickel to determine whether similar patterns are found in subjects
sensitized to these contact allergens, and previously published ana-
lyses of MI have been extended. Finally, experiments were performed
to determine whether sensitization to PPD or nickel (and also to MI) is
associated with changes in the relative frequency in peripheral blood
of regulatory T cells (Tregs)17 or skin-homing (cutaneous lymphocyte
antigen [CLA]+) T lymphocytes.18
2 | MATERIALS AND METHODS
2.1 | Patient recruitment
A total of 192 individuals were recruited to this study (NRES Ethics
Committee North West-Greater Manchester East [12/NW/0602]). All
subjects were recruited from patients attending the Contact Derma-
tology Investigation Unit at Salford Royal Hospital for diagnosis of
contact allergy who gave their informed consent to participate in this
study. Of the 57 individuals recruited who were allergic to nickel, five
were also allergic to PPD. Of the 53 individuals recruited who were
allergic to PPD, five were also allergic to nickel. In addition to the
56 individuals with MI allergy who had been reported in the previous
publication,7 a further 27 individuals were recruited, of whom eight
also had an allergy to nickel or PPD.
2.2 | Healthy volunteers
Blood samples were obtained from generally healthy individuals who
met the NHS Blood and Transplant Service screening criteria for blood
donation (n = 14). Samples were obtained in the form of a “buffy
coat” preparation, which was prepared by centrifugation of whole
blood at 18C within 24 hours of blood draw, and was received by
our laboratory for processing within the following 48 hours.
2.3 | Patch testing and blood draw
Patch testing was performed on the skin of the upper back with Finn
Chambers (inner diameter, 8 mm) that contained potential contact
allergens at a standard concentration (nickel, 5% [as nickel sulfate];
PPD, 1%; MI, 0.2%). After 4 days, patients’ reactions were scored
as no reaction (−), weak positive (+), strong positive (++), or extreme
positive (+++), according to standards set by the ICDRG, and up to
30 mL of peripheral blood was collected in a lithium heparin-coated
collection tube (Sigma Aldrich, St Louis, Missouri). Of the patients rec-
ruited, six consented to an additional, pre-patch test blood draw of up
to 30 mL, which was taken immediately before application of the Finn
Chambers. This was in addition to the post-patch test blood sample,
which was taken 4 days after application of the Finn Chambers as
standard.
2.4 | Peripheral blood mononuclear cell isolation
Peripheral blood mononuclear cells (PBMCs) were isolated by centri-
fugation (500g, 30 minutes, no brake) of a maximum of 30 mL of
whole blood (diluted 1:1 in phosphate-buffered saline [PBS]), layered
over an equal volume of Histopaque 1077 (Sigma Aldrich), according
to the manufacturer’s protocol. An aliquot of 1 × 106 cells was col-
lected and stored in 10% dimethylsulfoxide/90% human AB serum
(Sigma Aldrich) at –80C for flow cytometric analysis, and the
remaining cells were cultured for thymidine incorporation assays. Cells
for thymidine incorporation assays were cultured as described previ-
ously2 in the presence or absence of cognate contact allergen or car-
rier control (nickel sulfate, 0.5-50 μg/mL; free PPD, 0.01-1 μg/mL;
PPD conjugated to human serum albumin [HSA], 10-100 μg/mL; HSA
alone, 100 μg/mL), or in medium alone.
2.5 | Preparation of PPD conjugates
PPD conjugates were prepared as previously described.3 Briefly, four
separate preparations of PPD-HSA were made by incubating 15 mM
PPD (Sigma Aldrich; ×100 molar excess) with 10 mg/mL (150 μM)
HSA (Sigma Aldrich) in PBS for 2 days. After dialysis against PBS for
3 days, the solution was lyophilized for 24 hours and stored at –80C
until required. PPD-HSA was dissolved in PBS for cell activation. Only
two of the batches of conjugate resulted in cell activation; these
batches were used for subsequent experiments. New batches of PPD-
BSA were tested in a proliferation assay alongside the existing batch
with both patient samples and negative control samples. Only those
new batches giving comparable results to the existing batch were
used in subsequent assays.
2.6 | Thymidine incorporation assays
Thymidine incorporation assays were performed on freshly isolated
cells cultured for 5 days as described above. For the final 16 to
20 hours of culture, cells were pulsed with 22.2 μBq of [3H]thymidine
(specific activity, 2 Ci/mmol; Amersham International, Amersham, UK)
per well. Cells were harvested into scintillation fluid, and incorporation
of tritiated thymidine was measured by β-scintillation counting. A pos-
itive proliferative response was defined as one that resulted in a stim-
ulation index (SI: mean disintegrations per minute of test sample
divided by mean disintegrations per minute of medium-alone control
sample) of ≥2.5 as compared with control (medium-only) cells.2
2.7 | Flow cytometric analyses
Flow cytometric analyses of T cell population composition were per-
formed with a standard protocol and one of four antibody panels
designed to detect CD4+ T cell subsets, CD8+ T cell subsets, Tregs,
and expression of CLA by CD4+ and CD8+ cells, respectively. All cells
used for flow cytometric analysis had been frozen upon receipt at the
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laboratory, and were thawed prior to staining. Antibody panels were
as follows: panel 1—allophycocyanin (APC)-anti-CD4, fluorescein iso-
thiocyanate (FITC)-anti-CD45RA, and phycoerythrin (PE).Cy5-anti-
CD27; panel 2—APC-anti-CD8, FITC-anti-CD45RA, and PE.Cy5-anti-
CD27; panel 3—FITC-anti-CD4 and APC-anti-CD25 pool, and PE-
anti-FoxP3; and panel 4—FITC-anti-CD4, PE.Cy5-anti-CD8, and
eFluor660-anti-CLA. All antibodies were from eBioscience (San Diego,
California), and were used at 1:20 dilution, with staining carried out in
flow cytometry staining buffer for 30 minutes at 4C. Single-stained
controls were used to set compensation settings prior to acquisition,
and to establish a compensation matrix for data analysis. Flow cyto-
metry was performed on a minimum of 10 000 cells with a FACS-
calibur (Becton Dickinson, Mountain View, California). FLOWJO
(TreeStar, Ashland, Oregon) was used for analysis. Gating was stan-
dardized across all samples. Non-viable cells and debris were excluded
from analyses by gating on the viable lymphocyte population on the
basis of forward and side scatter. Gates were then drawn to delineate
the CD4+ population and the CD8hi population. For T cell subset anal-
ysis, quadrants were drawn to divide both the CD4+ population and
the CD8hi population into CD27+ CD45RA+ (naïve), CD27+ CD45RA−
(central memory), CD27− CD45RA− (effector memory) and CD27−
CD45RA+ (EMRA) subsets.19 Representative flow plots showing the
gating strategy for CD4+ and CD8hi cells are shown in Supplementary
Information Figure SS1. CD4/CD8 ratios were then calculated from
the percentage of CD4+ cells and the percentage of CD8hi cells of the
total viable lymphocytes. CLA+ cells were defined as those that
expressed CD4 or high levels of CD8, and also expressed CLA. Tregs
were defined as CD4+ CD25+ cells that also expressed FoxP3.
2.8 | Statistical analyses
Statistical analyses were performed with R (v3.2.5; R Core Team,
2016; RRID:SCR_001905). Unless otherwise stated, comparisons
were performed between samples taken from the general population
(“buffy coat” group) and each of the three sensitized subgroups (+, ++,
and +++). For the ratios of CD4+ to CD8hi cells for nickel-sensitive,
PPD-sensitive and MI-sensitive patients, abundance of Tregs, and
expression of CLA, the non-parametric Mann-Whitney U test was
used. For comparisons of distribution of CD4+ and CD8+ T cells across
the four T cell subsets, including in samples taken from the same indi-
vidual before and after patch testing, these compositional data were
first transformed by the use of an additive log ratio (as described in
Ref. 20) to remove linear dependence, and a paired Hotelling’s t2 test21
was then applied to test for significance of differences across the mul-
tivariate means.
3 | RESULTS
3.1 | Lymphocyte proliferative responses to contact
allergen
The vigour of the T cell response to contact allergen was assessed in
individuals identified by patch testing as being weakly (+), strongly (+
+) or extremely (+++) allergic to nickel or to PPD (a small number were
allergic to both, as detailed in Materials and Methods). PBMCs were
cultured for 120 hours with various concentrations of cognate aller-
gen, in the presence of radiolabelled thymidine for the final 16 to
20 hours of culture. An SI of ≥2.5 was regarded as being indicative of
a biologically meaningful level of proliferation.7 For nickel-sensitive
donors, the range of SI values recorded and the proportions of posi-
tive donors were similar for weakly (5/7) and strongly (7/12) allergic
individuals (Figure 1A). However, only 5 of 12 extremely allergic (+++)
donors achieved a positive SI. Previous reports have shown that,
despite individuals being strongly allergic to PPD, proliferative
responses to free organic PPD (rather than the known metabolite
Brandowski’s base) were either not detected or were detected in only
a minority of patients unless they had extremely severe allergic
reactions.11,22–24 Our approach was to prepare water-soluble conju-
gates of PPD with the carrier protein HSA; interestingly, although four
batches of conjugate were prepared under identical conditions, only
two of these conjugates elicited robust proliferative responses (data
not shown). Whereas negative or a minority of borderline positive
results were recorded in the presence of carrier protein alone, marked
proliferative responses were observed when cells were stimulated
with PPD-HSA conjugate, particularly in those individuals with +++
patch test scores (8/11) (Figure 1B). Fewer patients in the ++ and +
patch test groups had SI values of >2.5 (3/8 in each group). Interest-
ingly, this +++ cohort of patients also responded to free PPD in
greater numbers (14/16) and with greater vigour than did weakly (+;
2/13) or strongly allergic (++; 4/17) patients.
3.2 | Characterization of T lymphocyte naïve and
memory populations in peripheral blood of contact-
allergic individuals
We showed recently that the composition of the T cell compartment
in the peripheral blood of patients with allergy to MI was significantly
altered as compared with healthy (buffy coat) controls, with increases
in the proportions of naïve CD4+ and CD8+ T cells, and corresponding
decreases in the proportions of central memory, effector memory and
EMRA cells.7 For comparison, we have now characterized the T cell
populations in nickel-allergic and PPD-allergic patients by flow
cytometric analysis of the proportions of CD4+ and CD8+ T cells in
each of four T cell subsets, that is, naïve, central memory, EMRA, and
effector memory, defined on the basis of expression of CD27 and
CD45RA.19 The CD4+ or the CD8hi population was gated (Supporting
Information Figure 1), and the proportion of cells in each of four sub-
populations was determined in comparison with healthy (buffy coat)
control samples. The patient cohort for each contact allergen was sub-
divided on the basis of degree of allergy (+, ++, and +++) as described
previously. In nickel-allergic individuals, an increase in the proportion
of naïve CD4+ T cells and corresponding decreases in the proportions
of EMRA and effector memory cells were observed across all three
patient cohorts as compared with healthy controls, but these differ-
ences only reached statistical significance in the severely allergic
patients (+++) (P < 0.01; Figure 2A). The same analysis of the CD4+ T
cell compartment of PBMCs from PPD-allergic patients showed the
same trend of an increase in the proportion of the naïve cell subpopu-
lation with corresponding decreases in the proportions of EMRA and
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effector memory cells, but these differences did not reach statistical
significance (Figure 2B). The composition of the CD8hi T cell compart-
ment was then analysed for the cohorts of nickel-allergic and PPD-
allergic patients. The CD8hi population in both cohorts showed a
trend of an increased proportion of naïve cells, and reductions in the
EMRA and effector memory populations, as compared with healthy
controls. This change in population composition was statistically sig-
nificant in strongly nickel-allergic individuals (++) (P < 0.05; Figure 2C)
and in both the strongly (++) and extremely (+++) PPD-allergic cohorts
(P < 0.001 and P < 0.05, respectively; Figure 2D).
Given that the blood sampling in these studies was performed
4 days after the application of diagnostic patch tests, a potential
explanation for the expansion of the naïve T cell population and a con-
traction of memory populations in the allergic patients is that there is
recruitment of allergen-specific memory T cells to the site of applica-
tion, which decreases the numbers detectable in peripheral blood. To
examine this possibility, blood samples were taken from individuals
with either a weak (+) or a strong (++) allergy (n = 3 for both groups)
immediately prior to application of the suspected contact allergen for
patch testing, and at the standard time point (4 days after initiation of
patch testing). The proportions of CD4+ and CD8hi T cells in the naïve,
central memory, EMRA and effector memory subsets were then
analysed by flow cytometry as described previously (Figure 3).
Although there was some interindividual variation in the relative con-
tributions of the different subsets, it was notable that there were no
significant changes in either CD4 or CD8 cell phenotype with time,
even for those individuals who had the highest proportion of naïve
cells at the day 4 time point. This supports the hypothesis that individ-
uals with allergic contact dermatitis may have an expanded pool of
naïve T cells, and that this is independent of whether there is an ongo-
ing skin reaction.
Finally, the ratio of CD4+ to CD8hi cells was also calculated for
the same samples (Figure 4). For the buffy coat control donors, a mean
CD4+/CD8hi value of 2.6 was recorded, although there was
considerable interindividual variation. This is consistent with previous
studies of healthy donors, in which ratios of 2.0 and 2.3 were
observed.25,26 In the nickel-allergic cohort, a significant decrease in
the CD4+/CD8hi ratio was shown in strongly allergic individuals (++;
P < 0.05), whereas, in the PPD-allergic donors, there was a marked
decrease in the CD4+/CD8hi ratio in the weakly, strongly and
extremely allergic cohorts (combined population as compared with
buffy coat samples; P < 0.001). To complement the previous studies
of T cell dynamics in allergy to MI, the ratio of CD4+ to CD8hi cells
was measured for an additional cohort of 27 MI-allergic individuals (+,
14; ++, 7; +++, 6). Although the mean ratio of CD4+ to CD8hi cells in
the extremely allergic cohort was considerably lower than in healthy
controls (approximately 1.5 as compared with 2.6), the difference was
not statistically significant.
3.3 | Further phenotypic characterization of the T
lymphocyte population: contribution of Tregs and
CLA-positive cells
Additional flow cytometric analyses were then performed in order to
investigate further the phenotype of CD4+ and CD8hi T cells in
contact-allergic individuals (Figure 5). These analyses also incorpo-
rated a number of newly recruited MI-allergic patients. Tregs consti-
tute a subset of the CD4+ population that, in humans, can be defined
as CD25+ FoxP3+ CD4+ cells.17 Their role is to dampen inflammation,
and defective or reduced numbers of Tregs have been associated with
inflammatory and autoimmune diseases, including multiple sclerosis,
systemic lupus erythematosus, and atopic dermatitis.27,28 We there-
fore hypothesized that individuals with more severe nickel, PPD or MI
allergy would have reduced numbers of Tregs in peripheral blood.
Flow cytometry analysis was performed in which CD4+ cells from
allergic individuals or buffy coat controls were then gated for expres-
sion of both CD25 and FoxP3 (Figure 5A representative gating strat-
egy). The abundance of Tregs as a percentage of the CD4+ population
was then assessed for weakly (n = 22), strongly (n = 15) and
FIGURE 1 Proliferative responses of peripheral blood mononuclear cells (PBMCs) isolated from nickel-allergic or p-phenylenediamine (PPD)-
allergic individuals. PBMCs were isolated by density gradient centrifugation from nickel (A) or PPD (B) patch test-positive donors (n = 31 and
n = 46), grouped according to allergy severity. Cells were cultured in 96-well flat-bottomed plates, at 1 × 105 cells/well, stimulated with allergen
or cultured in the presence of medium alone, and incubated at 37C (≥triplicate wells) for 120 hours. Cells were pulsed with [3H]thymidine for the
final 16 to 20 hours of culture, and then harvested and processed for β-scintillation counting. PBMCs from nickel-allergic patients (A) were
stimulated with 0.5 to 50 μg/mL nickel sulfate (+, n = 7; ++, n = 12; +++, n = 12). PBMCs from PPD-allergic patients (B) were incubated with
0.01 to 1 μg/mL free PPD ((i) +, n = 13; (ii) ++, n = 17; (iii) +++, n = 16), and a subset was also stimulated with 10 to 100 μg/mL of one of two
PPD-human serum albumin (HSA) conjugates or with 100 μg/mL HSA (+, n = 8; ++, n = 8; +++, n = 11). For the allergen stimulation, the data
from the concentration that gave maximal proliferation are shown. Data are shown as a stimulation index (SI) (fold change in proliferation above
baseline [medium alone]) for individual patients (•) and mean and standard error of the mean per group; an SI of ≥2.5 was regarded as being
indicative of cellular proliferation (illustrated with horizontal dotted lines)
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extremely (n = 12) allergic individuals (pooled across the allergens
nickel, PPD, and MI), as well as for nine buffy coat controls. For the
buffy coat controls, Tregs constituted ~1.1% of the total CD4+ popu-
lation, which is somewhat lower than in previous reports, in which
3.2% of the CD4 population was identified as Tregs29 (Figure 4B).
Despite the relatively low control levels, a significant decrease in the
percentage of CD4+ cells that were Tregs was recorded for extremely
allergic individuals (Figure 5B; P < 0.05).
Finally, expression of the skin-homing marker CLA18 by CD4+ and
CD8hi cells was measured by flow cytometry, to determine whether
contact allergy was associated with an increase in CLA expression in
peripheral blood T cells (Figure 6). Representative flow cytometry
plots for (A) CD4+ cells and (B) CD8hi cells are shown in Figure 5.
Approximately 14% of healthy control (buffy coat) CD4+ cells
expressed CLA, consistent with previous publications, which also
reported ~14% CLA+ CD4+ cells in healthy controls.30 A marked
increase in the percentage of CLA+ CD4+ cells was recorded for all
three categories of patch test-positive individuals (+, P < 0.05; ++,
P < 0.001; +++, P < 0.05; pooled for PPD-allergic, MI-allergic or
nickel-allergic donors). For the CD8hi population, there was little
change in the number of CLA+ cells (~7%), but the mean level of CLA
expression (mean fluorescence intensity) was significantly elevated in
individuals strongly (++; P < 0.001) or extremely (+++; P < 0.05) aller-
gic to PPD, MI, or nickel. This indicates that increased CLA expression
may be a hallmark of allergic contact dermatitis, particularly in the
case of severe allergies.
FIGURE 2 T lymphocyte phenotype of freshly isolated peripheral blood mononuclear cells (PBMCs) of nickel-allergic and p-phenylenediamine
(PPD)-allergic patients: comparisons with buffy coat donors. PBMCs were isolated from nickel (A, C; n = 56) or PPD (B, D; n = 30) patch test-
positive donors'. The A and C for nickel and the B and D for PPD (in parentheses) refer to panels 2A-2D. Cells were stained with anti-human
CD4-allophycocyanin (APC), CD8-APC, CD45RA-fluorescein isothiocyanate and CD27-phycoerythrin-Cy5 antibodies. Data are shown as
percentage of total viable CD4+ or CD8hi cells in each phenotype (naïve [CD45RA+ CD27+] [i], central memory [CD45RA− CD27+] [ii], effector
memory RA [CD45RA+ CD27−] [iii], and effector memory [CD45RA− CD27−] [iv]) within the CD4+ (A, B) or CD8hi (C, D) T lymphocyte
populations. Donors were segregated according to patch test status (buffy coat donors [n = 14], + donors [nickel, n = 14; PPD, n = 8], ++ donors
[nickel, n = 27; PPD, n = 11], and +++ donors [nickel, n = 15; PPD, n = 11]), and data are shown as group mean (horizontal line) and standard
error of the mean and for each individual donor (). Statistically significant shifts (Hotelling’s t2 test after additive-log-ratio transformation) as
compared with buffy coat controls were seen in CD4+ population composition in patients with severe nickel allergy (P < 0.01) and in CD8hi
population composition in patients with moderate nickel allergy (P < 0.05), and in patients with moderate or severe PPD allergy (P < 0.001 and
P < 0.05, respectively)
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FIGURE 3 Influence of patch test application on CD4 and CD8 cell phenotype. Peripheral blood mononuclear cells were isolated and stained as
described in the legend to Figure 2 for the identification of naïve, central memory, EMRA and effector memory CD4+ (A) and CD8hi (B) subsets.
Blood samples were drawn immediately before patch testing (black bars) and on day 4 after a positive patch test reaction (white bars) was
recorded for nickel, methylisothiazolinone, or p-phenylenediamine (PPD) for three individuals with weak (+) allergy and three individuals with
strong (++) allergy. The results are displayed as mean and standard error of the mean. There were no statistically significant changes in subset
composition with time (Hotelling’s one-sample t2 test after additive-log-ratio transformation)
FIGURE 4 Influence of allergy on CD4/CD8 cell ratio. Peripheral blood mononuclear cells (PBMCs) were isolated and stained as described in the
legend to Figure 2 for the identification of CD4+ and CD8hi subsets. The percentage of CD4+ and CD8hi cells in each PBMC sample was
calculated as a function of the total viable cell population, and is displayed as a ratio of CD4+ to CD8hi cells. PBMCs from methylisothiazolinone
(MI)-allergic (n = 27), nickel-allergic (n = 56) and p-phenylenediamine (PPD)-allergic (n = 30) patients were compared with those from healthy
(buffy coat) donors (n = 14). Patients were segregated according to patch test status, that is, + donors (MI, n = 14; nickel, n = 14; PPD, n = 9), ++
donors (MI, n = 7; nickel, n = 27; PPD, n = 10), and +++ donors (MI, n = 6; nickel, n = 15; PPD, n = 11), and data are shown as group mean
(horizontal line) and standard error of the mean and for each individual donor (). Statistically significant differences vs buffy coat donors were
assessed with the Mann-Whitney U test. *P < 0.05; ***P < 0.001
FIGURE 5 Association of severe contact allergy with decreased regulatory T cell (Treg) cell numbers. (A) Peripheral blood mononuclear cells
(PBMCs) were isolated from individuals allergic to nickel (n = 30), p-phenylenediamine (PPD) (n = 5), or methylisothiazolinone (MI) (n = 14), or
from buffy coat samples (n = 9), and stained with anti-human CD4/CD25-fluorescein isothiocyanate (FITC)/allophycocyanin (APC) antibody
cocktail, and anti-human FoxP3-phycoerythrin (PE) for flow cytometric analysis. Data are shown as the proportion of CD4+ PBMCs coexpressing
(i) CD25 and (ii) FoxP3, and therefore classed as Tregs. (B) The individuals analysed constituted a subset of the total allergic population, and were
mildly (+), moderately (++) or strongly (+++) allergic to nickel (closed circles: +, n = 11; ++, n = 10; +++, n = 9), PPD (open circles: +, n = 3; ++,
n = 1; +++, n = 1), or MI (half-filled circles: +, n = 8; ++, n = 4; +++, n = 2). Statistically significant differences vs buffy coat donors (n = 9) were
assessed with the Mann-Whitney U test; *P < 0.05. Line and error bars indicate mean and standard error of the mean
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4 | DISCUSSION
In the current study, T lymphocyte responses have been characterized
in individuals with contact allergy to nickel, which, despite Europe-
wide attempts to reduce exposure, remains one of the most common
skin sensitizers,31,32 and to PPD, which is a potent allergen and a
major cause of adverse reactions to hair dyes.33,34 Consistent with
previous analyses of PBMCs derived from MI-sensitized individuals,7
patch test positivity for both nickel and PPD was associated with
increases in the proportions of both naïve CD4+ and naïve CD8+ lym-
phocytes, with corresponding decreases in the EMRA and effector
memory cell populations. It should, however, be noted that statistical
significance was seen only in severely allergic patients. The healthy
control comparator population of PBMCs utilized in the study
FIGURE 6 Expression of cutaneous lymphocyte antigen (CLA) on CD4 and CD8 cells: comparisons with buffy coat donors. Peripheral blood
mononuclear cells (PBMCs) were isolated from individuals allergic to nickel (n = 28), p-phenylenediamine (PPD) (n = 6), or methylisothiazolinone
(MI) (n = 9), or from ‘buffy coat’ samples representative of the general population, and stained with anti-human CD4-fluorescein isothiocyanate,
CD8-phycoerythrin-Cy5, and CLA-eFluor660. A representative gating strategy is shown in (A) and (B) for analysis by flow cytometry of CLA
expression by (C) the CD4+ and (D) the CD8hi PBMC subsets. For each of (A) and (B), panel (i) indicates expression of CLA by buffy coat samples, and
panel (ii) indicates CLA expression by patient-derived cells. For the CD4+ subset, the proportion of CD4+ cells expressing CLA is shown. For CD8hi
cells, the mean fluorescence intensity of CLA-eFluor660 as a proxy for surface levels of CLA is shown. Data are from a pool of individuals who were
weakly (+), strongly (++) or extremely (+++) allergic to nickel (half-filled circles: +, n = 9; ++, n = 10; +++, n = 9), PPD (filled circles: +, n = 4; ++, n = 1;
+++, n = 1), or MI (open circles: +, n = 3; ++, n = 4; +++, n = 2), and buffy coat controls (n = 10). Significant differences vs the buffy coat population
were analysed with the Mann-Whitney U test. *P < 0.05; ***P < 0.001. Error bars indicate standard error of the mean. APC, allophycocyanin
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reported herein was isolated from buffy coat samples (n = 14). It
could be argued that this was an inappropriate control, as there are
differences in the storage and isolation procedure as compared with
the patch test donor samples. Whereas patch test donor PBMCs are
isolated from blood within hours of blood being drawn and then snap-
frozen prior to phenotypic analyses, buffy coats are prepared within
24 hours of venepuncture, received in the laboratory for PBMC prep-
aration within 48 hours, and then snap-frozen. However, there are
several studies that have compared directly freshly isolated and buffy
coat PBMCs, and these have concluded that there are no significant
differences in cell viability and purity and CD4/CD8 phenotype
between the two preparation methods.35,36 The parameter that is
most likely to impact on cell phenotype is freeze/thawing37; given
that both patch test-positive patient samples and buffy coats are fro-
zen once PBMCs have been isolated, this should not be a cause for
concern. Reference data for the distribution of naïve, central memory,
effector memory and EMRA T cell subsets in peripheral whole blood
anticoagulated with EDTA are available from a cohort of 253 healthy
adults aged between 19 and 67 years.38 The distribution of subsets
among CD4+ cells was similar to the buffy coat data reported herein
(mean values: naïve, 43.1% [vs ~32%]; central memory, 32.8%
[vs ~38%]; and effector memory, 16.7% [vs ~20%]), with the excep-
tion of the EMRA subset, which was somewhat larger in the buffy
coat samples, although still the smallest subset (~10% vs 1.6%). For
CD8+ cell subsets, taking into account the markers that were used in
the two different studies, there were more differences between these
control data and the buffy coat data, but values were broadly similar
(mean values: naïve, 44.6% [vs ~35%]; effector memory, 4.7%
[vs ~14%]; EMRA, 9.9% [vs ~16%]; and central memory, 28.5%
[vs 35%]). Taken together, these data suggest not only that the buffy
coat sample represents an appropriate control for the patch test-
positive donor samples, but also that the patch test-positive donor
samples show a different distribution from that in healthy control
samples. Had it been possible to obtain such samples, a more appro-
priate negative control would have been individuals who were patch-
test negative for all patch tests applied; however, during the course of
the study, only one such individual was identified.
One additional technical issue regarding the study design was
that, in order to be confident of the identity of the allergen to which
the patch test-positive donors were allergic, blood samples were
drawn 4 days after the initial application of the patch tests, on the day
of patch test reading. In other studies using peripheral blood samples
taken from patients with contact allergy, blood sampling has tended
to be conducted before patch testing, as the authors were concerned
that exposure to contact allergen might activate the cells.15,39 Alterna-
tively, donors have been drawn from a pool of previously patch test-
positive or patch test-negative individuals.40 Given that significant dif-
ferences were found between the phenotype of the healthy control
population and that of the nickel-positive and PPD-positive donors in
our study, particularly with respect to increases in the proportions of
naïve CD4+ and CD8hi cells, it is possible that the observed differ-
ences were attributable to cellular recruitment of skin-homing lym-
phocytes to the patch test site. For a subset of donors, we therefore
took blood samples before and 4 days after patch test application.
There were no significant differences observed in the phenotype of
CD4+ or CD8hi T cells in samples taken prior to and after patch test
readings, suggesting that individuals with allergic contact dermatitis
do indeed have an expanded pool of naïve T cells and reduced effec-
tor memory and EMRA cell numbers, regardless of an ongoing skin
patch test response. Because of low sample numbers, it was not possi-
ble to determine whether ongoing patch test inflammation was con-
tributing to the alteration in Treg numbers or CLA expression.
It should be noted that peripheral blood T cell phenotypes show
considerable interindividual (and intraindividual) variation, and can be
influenced by factors such as age and disease, with, for example, cyto-
megalovirus infection resulting in decreasing numbers of naïve CD4+
T cells41 and decreased numbers of both CD4 and CD8 naïve cells
being reported with age.42,43 However, it is of interest that an
expanded pool of naïve T cells was recorded in patients with allergy
to nickel and PPD, and, in a previous publication, to MI,7 suggesting
that this might be a common feature of contact allergy. Increased
levels of naïve T cells could result from the release from the bone mar-
row and thymus of increased numbers of naïve T cells and T cell pre-
cursors, or from increased survival of these cells. It is known that the
half-life of naïve human T cells is ~50 days, and that survival of naïve
T lymphocytes requires signalling from interleukin (IL)-7.44 It is there-
fore possible that the general systemic cytokine milieu that is a result
of contact allergy provides an environment for improved naïve T cell
survival, through increased levels of cytokines such as IL-7.
The ability of PBMCs from allergic individuals to proliferate in
vitro in response to challenge with contact allergen was also examined
with a lymphocyte transformation test. There is considerable interest
in developing such in vitro measures of allergen-specific responses in
order to supplement, or perhaps even to replace, patch testing when
there are concerns about severe reactions or unintended
sensitization.8–15 In the absence of cytokine supplements (IL-2 or IL-7,
for example)11,39 being used to enhance proliferative responses, the
overall positive rate for nickel was 17 of 31, which is lower than the
rate found in many other reported studies (16/18; 62/74; and
13/14),15,39,40 although it is similar to the frequency of 13 of
19 reported in 2013 by Pacheco et al for patients referred by local
orthopaedists for evaluation for possible nickel sensitization who
were patch test-positive.45 The reasons for this lower share of positiv-
ity in our study are not clear, although it is noted that minor technical
differences in the lymphocyte transformation test protocol can have
marked effects, such as the use of autologous serum,46 or the length
of time in culture (5 days vs 6 or 7 days).39,40,47 The lowest number of
responders (5/12) was recorded for the extremely (+++) sensitized
group, although mean proliferation was similar between the ++ and +
++ groups. This inverse dose-response relationship may indicate that
the culture conditions were not optimal, rather than a true negative
correlation of proliferation with patch test sensitivity. In general, con-
cerns regarding nickel and the measurement of proliferative responses
tend to be related to non-specific responses in negative control
groups (false positives), so alternative endpoints are being investi-
gated. Cytokine expression profiling, including the ratio of IL-5 to IL-8
production47 or the secretion of interferon-γ, are being explored cur-
rently.48 Experience with PPD is rather more variable, with some
groups reporting vigorous proliferative responses to free PPD (6 of
9 +++ patch test donors; 7 of 8 ++ or +++ patch test donors; and
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10 of 11 donors said to have a strong history of sensitization to
PPD).11,12,24 However, other studies found that free PPD stimulated
proliferative responses in a minority of donors (1/6), despite them
having ++ or +++ scores in patch tests,49 or that 0 of 9 sensitized
donors reacted positively to free PPD, although 7 of 9 responded to
the metabolite Brandowski’s base.22 We previously observed, with a
different cohort of PPD patch test-positive donors, that PPD alone
gave variable responses in a minority of individuals, and that PPD-
HSA conjugates were more successful at stimulating proliferative
responses, with the most vigorous effects being observed among the
+++ patch test group.6 In the current study, free PPD was more effec-
tive in the +++ patch test-positive group, but the conjugate was more
effective at provoking significant levels of thymidine incorporation in
the more weakly sensitized groups. Given the level of sensitivity, the
number of false negatives, and interlaboratory variation, the lympho-
cyte transformation test seems very unlikely to be a replacement for
patch testing, but does have the advantages that additional endpoints
such as the identity of the proliferating cells (CD4 or CD8) or the
nature of cytokine production can be incorporated to improve mecha-
nistic understanding.7,47,48
In addition to sensitization being associated with changes in the
profile of naïve and effector/central memory and EMRA cells, we also
observed that, particularly for extremely allergic individuals, the Treg
frequency was decreased, as was the CD4+/CD8hi ratio, whereas CLA
expression was increased. These findings appeared to be a feature of
sensitization to each of the three different allergens, despite the fact
that they have very different chemistries. It has been shown previ-
ously that PBMCs from nickel-allergic individuals express lower levels
of the Treg cytokines IL-10 and transforming growth factor-β,39 and
that their Tregs had limited suppressive capacity as compared with
those from nickel non-allergic individuals.49 There has been one previ-
ous report that allergic contact dermatitis is associated with a
decreased frequency of Tregs. As compared with healthy controls
(4.06% Tregs), significantly decreased levels of Tregs were recorded
(1.6%) in eight individuals with skin sensitization to unspecified aller-
gens, despite the fact that the average length of time since diagnosis
was only 54 days.27 Perhaps the most interesting report came from a
study of melanoma patients who received an in vivo infusion of a
recombinant IL-2-diphtheria toxin fusion protein, which depleted
Tregs from ~3% (3.5%-2%) to ~2% (2.5%-1%) of CD4+ cells. Prior to
depletion, only weak contact allergic responses were provoked by
sensitization with the potent contact allergen diphencyprone,
whereas, after depletion, very vigorous elicitation reactions to this
allergen were recorded.50 If a reduced frequency of Tregs is a feature
of contact allergy, particularly severe contact allergy, then this could
be a factor in polysensitization, as those individuals with +++ patch
test scores, and potentially low Treg numbers, have a higher risk of
becoming polysensitized.51 In this study, individuals with +++ patch
test scores for nickel and MI also tended to have positive patch test
reactions to other allergens.
There are reports that suggest that CD4+ cells may be more prev-
alent in skin lesions52; however, it is generally accepted that both
CD4+ and CD8+ cells producing interferon-γ, IL-17 and IL-22 are
involved in contact allergic responses.1,53–55 To our knowledge, there
are no previous reports showing that contact allergy is associated with
increased numbers of total CD8+ cells and a decreased numbers of
total CD4+ cells. This is also not a feature of other forms of allergic
disease such as allergic asthma, as even severe asthmatics had CD4+/
CD8+ ratios similar to those of healthy controls.56 There are other sit-
uations in which decreased CD4/CD8 cell ratios have been recorded;
in early menopause with inadequate oestrogen levels, for example,
where they can be restored with hormone replacement therapy (from
1.4% ± 0.16 to 2.4% ± 0.3%),57 or with immune senescence resulting
from ageing.58 Viral infection, particularly cytomegalovirus infection,
is also associated with a similar increase in the CD4/CD8 ratio
through an expansion of CD8 cells, although these tend to be in the
EM and EMRA T cell compartments rather than naïve T cells.59 Other
chronic infections, such as tuberculosis, dimorphic fungal infections,
toxoplasmosis, and leishmaniasis, also lead to CD8 expansion with
altered ratios.60 It therefore seems likely that the inverted CD4/CD8
ratio observed in highly sensitized donors is attributable to an
expanded CD8+ T cell population.
The final features of T cells isolated from sensitized individuals
were increased numbers of skin-homing marker CLA+ CD4 cells and
increased expression of this marker on CD8 cells. It is well accepted
that skin-resident T cells are CLA+; indeed, it has been calculated,
from comparisons of the frequency of these cells in skin and blood
and the relative volume/surface area of blood and skin, that 98% of
CLA effector memory T cells are found in the skin.61–63 In peripheral
blood, this marker has been reported to be expressed on 17% of CD4
cells and 11% of CD8 cells,64 primarily on central and effector mem-
ory cells.65 To our knowledge, this marker has not been examined sys-
tematically in peripheral blood of contact-allergic patients, or
previously correlated with the severity of allergy. It may be that
this increase in CLA expression reflects activation of T cells as a
result of the patch test applied 4 days prior to the blood draw, or
could represent a bystander effect, with cytokines produced by
allergen-specific T cells non-specifically activating other T
lymphocytes.66
In conclusion, these studies have shown that patch test positivity
for nickel, PPD and MI is associated with changes in the phenotype of
peripheral blood T cells: increases in the numbers of naïve cells,
decreases in Treg frequency and the CD4+/CD8hi ratio, and increased
expression of the skin-homing marker CLA. This increased under-
standing of the characteristics of the T cell response to contact aller-
gens may provide insights regarding useful parameters to consider in
the development of health risk assessment models for chemical skin
sensitizers.
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